We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Moderate Steroid Use Does Not Increase Fractures

By HospiMedica staff writers
Posted on 15 Jan 2004
A large-scale study of patients over 65 who used inhaled or nasal steroids for four years or more at the usual doctor-recommended dose has found that this use did not increase their risk of fracture. More...
The results were published in the January 1, 2004, issue of the American Journal of Respiratory and Critical Care Medicine.

The study involved more than 133,000 patients as well as more than 191,000 age-matched controls whose average age was 81. After a four-year follow-up, there were 9,624 new cases of fracture of either the hip or lower extremities. However, researchers found that the rate of fracture associated with the use of inhaled or nasal corticosteroids during the four-year period was no different between the two groups. There had been concerns about the safety of long-term use of steroids and its potential for increasing fracture risk. Investigators found that only high doses of more than 2,000 mg daily for an average of six years or more was associated with extra risk of fracture.

The study was conducted by researchers from McGill University (Montreal, Canada) and Mount Sinai Medical Center (New York, NY, USA).




Related Links:
McGill U.
Mount Sinai

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.